Sale!

Medullary Thyroid Carcinoma Mutation Detection Test

Original price was: $626.Current price is: $500.

-20%

The Medullary Thyroid Carcinoma Mutation Detection Test is a cutting-edge genetic screening that identifies RET proto-oncogene mutations associated with medullary thyroid cancer. This comprehensive molecular diagnostic test provides crucial information for early cancer detection, especially in individuals with family history of thyroid cancer or Multiple Endocrine Neoplasia type 2. By detecting specific genetic mutations, the test enables proactive medical management and personalized treatment strategies. The test costs $500 USD and delivers results within 10 working days, offering peace of mind through advanced genetic analysis.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Medullary Thyroid Carcinoma Mutation Detection Test

Understanding Medullary Thyroid Carcinoma Genetic Testing

Medullary Thyroid Carcinoma (MTC) represents approximately 3-5% of all thyroid cancers and originates from the parafollicular C-cells of the thyroid gland. Unlike other thyroid cancers, MTC has a strong genetic component, with up to 25% of cases being hereditary. The Medullary Thyroid Carcinoma Mutation Detection Test is a sophisticated molecular diagnostic tool that identifies specific genetic mutations in the RET proto-oncogene, providing critical information for early detection, risk assessment, and personalized treatment planning.

What This Advanced Genetic Test Measures

This comprehensive genetic screening specifically targets mutations in the RET (Rearranged during Transfection) proto-oncogene, which plays a pivotal role in the development of medullary thyroid carcinoma. The test analyzes:

  • RET gene mutations associated with Multiple Endocrine Neoplasia type 2 (MEN2)
  • Specific codon mutations including 634, 918, and other high-risk variants
  • Germline mutations that indicate hereditary cancer predisposition
  • Somatic mutations in sporadic MTC cases

Who Should Consider Genetic Testing for MTC

This genetic screening is particularly important for individuals with:

  • Family history of medullary thyroid carcinoma
  • Personal or family history of Multiple Endocrine Neoplasia type 2
  • Elevated calcitonin levels without obvious thyroid abnormalities
  • Unexplained thyroid nodules or masses
  • Diagnosis of pheochromocytoma or hyperparathyroidism
  • Planning for preventive thyroidectomy in high-risk individuals

Clinical Symptoms and Risk Factors

Individuals experiencing symptoms such as neck swelling, difficulty swallowing, hoarseness, or persistent cough should consider genetic testing, especially when accompanied by:

  • Family history of endocrine tumors
  • Multiple endocrine abnormalities
  • Early-onset thyroid cancer in family members
  • Known RET mutation carriers in the family

Significant Benefits of Genetic Testing

Undergoing Medullary Thyroid Carcinoma Mutation Detection provides numerous advantages:

  • Early Intervention: Enables proactive medical management before cancer develops
  • Personalized Screening: Tailors surveillance protocols based on genetic risk
  • Family Planning: Provides crucial information for genetic counseling and family decisions
  • Treatment Guidance: Informs surgical timing and approach for at-risk individuals
  • Peace of Mind: Reduces uncertainty through definitive genetic information

Understanding Your Test Results

Your genetic test results will fall into one of several categories:

  • Positive for Mutation: Indicates increased cancer risk requiring specialized monitoring and potential preventive measures
  • Negative Result: Suggests standard population risk for MTC development
  • Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation

All results should be discussed with a qualified genetic counselor or oncologist who can provide personalized interpretation and management recommendations based on your specific genetic findings and family history.

Test Pricing and Availability

Test Option Price (USD)
Discount Price $500
Regular Price $626

Testing Process and Timeline

Our advanced molecular diagnostics laboratory processes samples daily with the following specifications:

  • Sample Collection: 4 mL (2 mL minimum) whole blood in 1 Lavender top (EDTA) tube
  • Shipping Requirements: Ship refrigerated – DO NOT FREEZE
  • Required Documentation: Duly filled Genomics Clinical Information Requisition Form (Form 20)
  • Turnaround Time: 10 working days from sample receipt
  • Sample Submission: Daily by 11 AM for same-day processing

Nationwide Accessibility

General Genetics Corporation provides comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Control of Your Genetic Health

Don’t wait to get the critical genetic information that could impact your health and your family’s future. Our team of genetic specialists and oncologists are ready to guide you through the testing process and provide comprehensive result interpretation.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Medullary Thyroid Carcinoma Mutation Detection Test and take the first step toward proactive cancer prevention and personalized healthcare management.